Investigating how genetic factors related to sex influence Alzheimer's disease.

Sex-Specific Genetic Drivers of Alzheimer's Disease Endophenotypes

NIH-funded research Vanderbilt University Medical Center · NIH-10862777

This study is looking at how genetic differences between men and women might influence how Alzheimer's disease develops and progresses, with the hope of finding better, personalized treatments for patients based on their unique genetic makeup.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center NIH-funded
Lab location1 site (Nashville, United States)
Project IDNIH-10862777 on NIH RePORTER

What this research studies

This research focuses on understanding how genetic differences between men and women affect the development and progression of Alzheimer's disease (AD). By analyzing data from 30 studies, the researchers aim to identify specific genetic drivers that contribute to the varying severity of symptoms and brain changes observed in male and female patients. The goal is to uncover sex-specific pathways that could lead to more personalized and effective treatments for Alzheimer's disease. Patients may benefit from insights that could tailor interventions based on their genetic profile.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease, particularly women, who may experience different disease manifestations.

Not a fit: Patients with early-onset Alzheimer's disease or those without a genetic predisposition to the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective, personalized treatments for Alzheimer's disease based on genetic differences between sexes.

How similar studies have performed: Previous research has shown promising results in identifying genetic factors influencing Alzheimer's disease, making this approach a continuation of successful methodologies.

Where this research is happening

Nashville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological markerAlzheimer's disease risk
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.